- In a report issued Monday, Jefferies analysts Eun K. Yang and Carmen Augustine shared a look into short interest in the biotech industry.
- According to the note, as of December 15, 2015, levels of weighted average short interest remained unchanged for large-cap (more than $10 billion in market cap) and mid-cap ($2 billion to $10 billion) biotech stocks.
- However, weighted average short interest levels rose 0.4 percent for smid-caps ($500 million to $2 billion) and decreased 0.8 percent for small-caps ($250M-$500M) and 0.9 percent for micro-caps (under $250 million).
In a recent report, analysts at Jefferies shared a look into short interest in the biotech industry. On top of the aggregate data referenced above, the experts took a look at the top 5 biggest increases in short interest and top 5 biotechs by short interest of float – which will be the focus of this article.
The experts assured that, overall, Global Blood Therapeutics Inc GBT saw the biggest percentage increase in short interest as a percentage of float (+4.5 percent), while KaloBios Pharmaceuticals Inc KBIO had the biggest percentage decrease (-15.2 percent).
Biggest Percentage Increases In Short Interest
The companies that witnessed the biggest percentage increases in short interest were:
Company % Change
Global Blood Therapeutics 4.5%
Clovis Oncology Inc CLVS 3.8%
bluebird bio Inc BLUE 3.0%
Epizyme Inc EPZM 2.7%
Puma Biotechnology Inc PBYI 2.5%
Highest Short Interest As A Percentage Of Float
Company Short Interest As % Of Float
Tokai Pharmaceuticals Inc TKAI 52.2%
MannKind Corporation MNKD 43.6%
Myriad Genetics, Inc. MYGN 34.2%
Orexigen Therapeutics, Inc. OREX 31.9%
KaloBios Pharmaceuticals Inc 31.5%
Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
